Vita Health Products Inc Pharmaceutical Import Profile — Canada (DGFT 2022–2026)

Name: Vita Health Products Inc Pharmaceutical Import Records from India — 3 Products, $3.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Vita Health Products Inc — Pharmaceutical Importer Profile (2026) | 3 Products, $3.3M Trade | TransData Nexus

Vita Health Products Inc

Pharmaceutical Importer · Canada · Respiratory & OTC Focus · $3.3M Total Trade · DGFT Verified

Vita Health Products Inc is a pharmaceutical importer based in Canada with a total trade value of $3.3M across 3 products in 2 therapeutic categories. Based on 66 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Vita Health Products Inc sources from 4 verified Indian suppliers, with Granules India Limited accounting for 60.9% of imports.

Vita Health Products Inc — Import Portfolio & Supplier Network

Vita Health Products Inc import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Vita Health Products Inc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Granules India Limited	$2.0M	49	60.9%
Marksans Pharma Limited	$1.2M	33	36.4%
Sri Krishna Pharmaceuticals Limited

What Formulations Does Vita Health Products Inc Import?

Formulation	Value	Ships
Ibuprofen 200MG and pseudoephedrine	$350.0K	7
Methocarbamol granules dc	$250.0K	5
Methocarbamol granules dc	$200.0K	4
Compresso pap 90	$150.0K	3
Pharmaceutical products - ibuprofen softgelatin capsules 200MG, batch no: 340168,340173,340174,340187,340188 mfg dt	$145.0K	3
Ibuprofen softgelatin capsules 200MG batch no: 330873330874330875330876 mfg dt: nov-2023 exp dt: oct-2025 (7385000	$124.0K	3
Ibuprofen 200MG and pseudoephedrine hcl30mg tablets pseudoephedrine(7947.503 pac) exp:pc-exp-2089/2023	$118.0K	3
Ibuprofen 200MG and pseudoephedrine hcl30mg tablets(qty:7955.520 pac)(export:pcexp182/2024 import:pi/0850/2023)	$117.6K	3
Ibuprofen 200MG and pseudoephedrine hcl30mg tablets(export permit:pc-exp-2081/2023 import	$114.5K	3
Pharma product-ibuprofen soft gelatin capsules 400 MG batch no	$100.0K	2
Ibuprofen softgelatin capsules 200MG batch no: 350143,350146,350152,350159 mfg dt: feb-2025 exp dt: jan-2027	$100.0K	2
Ibuprofen 200MG pseudoephedrine hcl 30MG	$89.3K	2
Ibuprofen soft gelatin capsules 400MG batch no: 350035,350036 mfg dt: jan-2025 exp dt: dec-2026 (qty:-1286000 capsule)	$71.9K	2
Ibuprofen 200MG,pseudoephedrine hcl 30MG	$70.1K	2
Methocarbamol granules dc	$50.0K	1

Vita Health Products Inc imports 49 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Pseudoephedrine	Respiratory & OTC	$1.6M	31	12.2%	2
2	Ephedrine	Respiratory & OTC	$1.4M	29	6.4%	3
3	Chlorpheniramine	Antihistamines & Allergy	$300.0K	6	0.7%	11

Vita Health Products Inc imports 3 pharmaceutical products across 2 categories into Canada totaling $3.3M.

Vita Health Products Inc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Vita Health Products Inc. is a Canadian company specializing in the manufacturing, packaging, and distribution of over-the-counter (OTC) pharmaceutical products and natural health products. Established in 1936 by G.W. Seier in Winnipeg, Manitoba, the company has evolved from a small mail-order operation into one of Canada's leading suppliers in its sector. With over 260,000 square feet dedicated to manufacturing, packaging, and distribution, Vita Health Products Inc. serves a diverse customer base across Canada.

The company's headquarters are located at 150 Beghin Avenue, Winnipeg, Manitoba, R2J 3W2. Vita Health Products Inc. operates as a non-distributing corporation with 50 or fewer shareholders, as per the Canada Business Corporations Act. The company employs between 201 and 500 individuals, reflecting its significant presence in the Canadian pharmaceutical industry.

2Distribution Network

Vita Health Products Inc. boasts an extensive distribution network across Canada, facilitated by its substantial manufacturing and packaging facilities in Winnipeg. The company's strategic location in the geographic center of Canada enables efficient logistics and timely delivery of products nationwide. While specific warehouse locations beyond Winnipeg are not publicly disclosed, the company's operations suggest a robust distribution capability to meet the demands of the Canadian market.

3Industry Role

Vita Health Products Inc. functions primarily as a manufacturer and distributor of OTC pharmaceutical products and natural health products within Canada's pharmaceutical supply chain. The company is not classified as a wholesaler, parallel importer, hospital supplier, or logistics intermediary. Its role centers on producing and delivering health products directly to consumers and retailers across Canada.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Vita Health Products Inc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Vita Health Products Inc. imports finished pharmaceutical formulations from four verified Indian suppliers, with Granules India Limited and Marksans Pharma Limited being the primary sources. Granules India Limited accounts for 60.9% of the total import value, while Marksans Pharma Limited contributes 36.4%. This concentration indicates a strategic sourcing approach, leveraging established relationships with key suppliers to ensure product quality and supply chain stability.

The company's portfolio is highly concentrated, with the top five imported products—Pseudoephedrine, Ephedrine, and Chlorpheniramine—comprising 100% of the import value. This focus suggests a deliberate strategy to specialize in specific therapeutic areas, potentially enhancing expertise and operational efficiency. However, such concentration also exposes the company to risks associated with supplier dependency and market fluctuations.

2Supply Chain Resilience

Vita Health Products Inc.'s supply chain resilience is supported by its partnerships with four verified Indian suppliers, including Granules India Limited and Marksans Pharma Limited. The company's importation of 49 unique formulations indicates a diversified product range, which can mitigate risks associated with over-reliance on a single product or supplier. While the primary suppliers are Granules India Limited and Marksans Pharma Limited, the inclusion of other suppliers provides alternative sources, enhancing supply chain flexibility.

Importing Pharmaceuticals into Canada — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Canada

1Regulatory Authority & Framework

In Canada, the regulation of pharmaceutical products is overseen by Health Canada, the federal department responsible for national health policy. The primary legislation governing pharmaceutical imports is the Food and Drugs Act, along with its associated regulations, which set out the requirements for the importation, sale, and distribution of drugs in Canada. (canada.ca)

The importation of pharmaceutical products into Canada is subject to strict regulatory controls to ensure public safety. All drugs imported into Canada must have a Drug Identification Number (DIN), which is issued by Health Canada upon approval of the product. Additionally, importers must hold an Establishment Licence (EL) for the activity of import, and the foreign manufacturing site must be listed on the importer's EL. (canada.ca)

2Import Licensing & GMP

Importers of pharmaceutical products into Canada are required to obtain an Establishment Licence (EL) for the activity of import. This licence ensures that the importer complies with the necessary regulatory requirements for importing drugs into Canada. The foreign manufacturing site must be listed on the importer's EL, indicating that the manufacturing facility meets Health Canada's standards for drug manufacturing. (canada.ca)

Good Manufacturing Practice (GMP) certification is a critical component of the importation process. Health Canada recognizes GMP certifications from various international bodies, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must ensure that their foreign suppliers hold valid GMP certifications from recognized authorities to demonstrate compliance with international quality standards. (canada.ca)

Vita Health Products Inc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Vita Health Products Inc. focuses on importing finished pharmaceutical formulations in the therapeutic categories of Respiratory & OTC and Antihistamines & Allergy. The company's top three imported products—Pseudoephedrine, Ephedrine, and Chlorpheniramine—align with these categories, indicating a strategic emphasis on respiratory and allergy treatments.

The market demand for these products is driven by the prevalence of respiratory and allergy-related conditions among the Canadian population. By concentrating on these therapeutic areas, Vita Health Products Inc. aims to address significant health concerns, positioning itself as a key player in providing effective OTC solutions for respiratory and allergy relief.

2Sourcing Profile

Vita Health Products Inc. employs a sourcing strategy that focuses on importing finished pharmaceutical formulations from India. This approach allows the company to leverage India's manufacturing capabilities, which are recognized for producing high-quality pharmaceutical products. By sourcing finished products, Vita Health Products Inc. ensures compliance with Canadian regulations and maintains control over product quality.

India's role in Vita Health Products Inc.'s procurement strategy is significant, as it provides a reliable source of pharmaceutical products that meet the company's quality standards. This sourcing strategy enables the company to offer a diverse range of products to the Canadian market, catering to various therapeutic needs.

Seller's Guide — How to Become a Supplier to Vita Health Products Inc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Vita Health Products Inc., given the company's focus on importing finished pharmaceutical formulations. Suppliers that can provide high-quality products in the therapeutic areas of Respiratory & OTC and Antihistamines & Allergy may find a receptive partner in Vita Health Products Inc.

Gaps in Vita Health Products Inc.'s current sourcing include potential opportunities to diversify its supplier base and product offerings. By exploring partnerships with additional suppliers, the company can

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Vita Health Products Inc

What products does Vita Health Products Inc import from India?

Vita Health Products Inc imports 3 pharmaceutical products across 2 categories. Top imports: Pseudoephedrine ($1.6M), Ephedrine ($1.4M), Chlorpheniramine ($300.0K).

Who supplies pharmaceuticals to Vita Health Products Inc from India?

Vita Health Products Inc sources from 4 verified Indian suppliers. The primary supplier is Granules India Limited (60.9% of imports, $2.0M).

What is Vita Health Products Inc's total pharmaceutical import value?

Vita Health Products Inc's total pharmaceutical import value from India is $3.3M, based on 66 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Vita Health Products Inc focus on?

Vita Health Products Inc imports across 2 categories. The largest: Respiratory & OTC (90.9%), Antihistamines & Allergy (9.1%).

Get Full Vita Health Products Inc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.